1 |
Costa C, Scozzari G, Migliore E, Galassi C, Ciccone G, Ricciardelli G, Scarmozzino A, Angelone L, Cassoni P, Cavallo R; on behalf of the Collaborative Group. Cellular Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital. Vaccines 2022;10:1031. [DOI: 10.3390/vaccines10071031] [Reference Citation Analysis]
|
2 |
Milito C, Cinetto F, Palladino A, Garzi G, Punziano A, Lagnese G, Scarpa R, Rattazzi M, Pesce AM, Pulvirenti F, Di Napoli G, Spadaro G, Carsetti R, Quinti I. Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy. Biomedicines 2022;10:1026. [DOI: 10.3390/biomedicines10051026] [Reference Citation Analysis]
|
3 |
Pulvirenti F, Di Cecca S, Sinibaldi M, Piano Mortari E, Terreri S, Albano C, Guercio M, Sculco E, Milito C, Ferrari S, Locatelli F, Quintarelli C, Carsetti R, Quinti I. T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies. Cells 2022;11:1918. [PMID: 35741048 DOI: 10.3390/cells11121918] [Reference Citation Analysis]
|